IRON
Companies
NASDAQ
Disc Medicine Inc.
Health Care
$50.09
-$11.81 (-18.64%)
Price Chart
Overview
About IRON
disc medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis) in hematologic diseases. focused on the hepcidin pathway, the master regulator of iron metabolism, disc is advancing first-in-class therapies to transform the treatment of hematologic diseases.
Market Cap
$967.1M
Volume
21.5M
Avg. Volume
24.1M
P/E Ratio
-9.445817
Dividend Yield
0.00%
Employees
63.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.45
Low Correlation
Volatility
High (0.58)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, IRON shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025